995 resultados para Société-Radio-Canada
Resumo:
One hundred twenty-two early-stage anal canal cancer patients (median age: 69 years) were treated with curative radiotherapy with (70 patients) or without (52 patients) concomitant chemotherapy. Median follow-up was 65 months (range: 4-238). At multivariate analysis, concomitant chemotherapy significantly improved local control (p = .007). Local control significantly influenced all considered endpoints, except the metastases free survival. The global rates of G3-G4 acute and late toxicity were 13.1% and 8.2%, respectively, and they were not increased by concomitant chemotherapy. Finally, concomitant chemotherapy is efficacious and safe in the treatment of T1-2N0 anal canal cancer patients and should be prospectively studied.
Resumo:
1857 (T8,A27).
Resumo:
1858 (T9,A28).
Resumo:
1853 (T4).
Resumo:
1855 (A25,T6).
Resumo:
1859 (T10,A29).
Resumo:
1856 (T7,A26).
Resumo:
1854 (A24,T5).
Resumo:
1852 (T3,A22).
Resumo:
1900/02 (A2,N1)-1900/10 (A2,N5).
Resumo:
1899/01 (A1,N1)-1899/02.
Resumo:
Périodicité : Bimest
Resumo:
1891/07 (A38)-1891/12.
Resumo:
1895 (A42).